PRPO
Precipio IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$42.54M
P/E Ratio
—
EPS
$-0.45
Beta
1.38
52W High
$33.63
52W Low
$9.00
50-Day MA
$27.74
200-Day MA
$22.86
Dividend Yield
—
Profit Margin
-1.51%
Forward P/E
15.43
PEG Ratio
0.00
About Precipio Inc
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | $24.05M |
| Gross Profit (TTM) | $10.71M |
| EBITDA | 231,000 |
| Operating Margin | 8.09% |
| Return on Equity | -2.72% |
| Return on Assets | -3.92% |
| Revenue/Share (TTM) | $14.98 |
| Book Value | $8.18 |
| Price-to-Book | 3.02 |
| Price-to-Sales (TTM) | 1.77 |
| EV/Revenue | 1.692 |
| EV/EBITDA | 46.83 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.90% |
| Shares Outstanding | $1.79M |
| Float | $1.42M |
| % Insiders | 11.94% |
| % Institutions | 18.01% |
Historical Volatility
HV 10-Day
52.76%
HV 20-Day
76.58%
HV 30-Day
70.09%
HV 60-Day
67.34%
HV Rank
45.6%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026